TLR-dependent IL-4 production by invariant Vα14+Jα 18+ NKT cells to initiate contact sensitivity in vivo

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6390-6401

  Askenase, Philip W ^a   Itakura, Atsuko ^a   Leite De Moraes, Maria C ^b   Lisbonne, Mariette ^b   Roongapinun, Sukit ^a   Goldstein, Daniel R ^a   Szczepanik, Marian ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CONTACT SENSITIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; IN VIVO STUDY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 27744600965     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6390     Document Type: Article

References (48)

1. Hoebe, K., E. Janssen, and B. Beutler. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5: 971-974.
2. Janeway, C. A., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
3. Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular patters by TLR family. Immunol. Lett. 85: 85-95.
4. Tapping, R. I., S. Akashi, K. Miyake, P. J. Godowski, and P. S. Tobias. 2000. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165: 5780-5787.
5. Tsuji, R. F., M. Kikuchi, and P. W. Askenase. 1996. Possible involvement of C5/C5a in the efferent phase of contact sensitivity. J. Immunol. 156: 4644-4650.
6. Tsuji, R. F., G. P. Geba, Y. Wang, K. Kawamoto, L. Malis, and P. W. Askenase. 1997. Required early complement activation in contact sensitivity with generation of C5-dependent chemotactic activity and late T cell IFN-γ: a possible initiating role of B cells. J. Exp. Med. 186: 1015-1026.
7. Tsuji, R. F., I. Kawikova, R. Ramabhadran, M. Akahira-Azuma, D. Taub, T. E. Hugli, C. Gerard, and P. W. Askenase. 2000. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165: 1588-1598.
8. Szczepanik, M., M. Akahira-Azuma, K. Bryniarski, R. F. Tsuji, I. Kawikova, W. Ptak, C. Kiener, R. A. Campos, and P. W. Askenase. 2003. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J. Immunol. 171: 6225-6235.
9. d mast cell deficient mice. J. Immunol. 131: 2687-2694.
10. Van Loveren, H., S. Kraeuter-Kops, and P. W. Askenase. 1984. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur. J. Immunol. 14: 40-47.
11. Van Loveren, H., R. Meade, and P. W. Askenase. 1983. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J. Exp. Med. 157: 1604-1617.
12. Geba, G. P., W. Ptak, G. A. Anderson, R. E. Ratzlaff, J. Levin, and P. W. Askenase. 1996. Delayed-type hypersensitivity in mast cell deficient mice: dependence on platelets for expression of contact sensitivity. J. Immunol. 157: 557-565.
13. Matsuda, H., H. Ushio, G. P. Geba, and P. W. Askenase. 1997.,Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibody. J. Immunol. 158: 2891-2897.
14. Van Loveren, H., and P. W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133: 2397-2401.
15. + T cell populations that mediate delayed-type hypersensitivity. J. Immunol. 133: 2402-2411.
16. + lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J. Exp. Med. 199: 1223-1234.
17. Tsuji, R. F., M. Szzcepanik, I. Kawikova, V. Paliwal, R. A. Campos, A. Itakura, M. Akahira-Azuma, N. Baumgarth, L. A. Herzenberg, and P. W. Askenase. 2002. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196: 1277-1290.
18. Gershon, R. K., P. W. Askenase, and M. Gershon. 1975. Requirement for vasoactive amines in the production of the skin reactions of delayed-type hypersensitivity. J. Exp. Med. 142: 732-747.
19. Schwanz, A., P. W. Askenase, and R. K. Gershon. 1977. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J. Immunol. 118: 159-165.
20. Askenase, P. W., S. Bursztajn, M. D. Gershon, and R. K. Gershon. 1980. T cell dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152: 1358-1374.
21. Van Loveren, H., S. Kraeuter-Kops, and P. W. Askenase. 1984. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur. J. Immunol. 14: 40-47.
22. Campos, R. A., M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P. W. Askenase. 2003. Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198: 1785-1796.
23. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
24. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57B1/10ScCr mice: mutations in TLR4 gene. Science 282: 2085-2088.
25. Zhou, D., J. Mattner, C. Cantu, 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1687-1689.
26. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD Id-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
27. Akashi, S., R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, M. Kimoto, and K. Miyake. 2000. Cell surface expression and lipopolycaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164: 3471-345.
28. Tamai, R., Y. Asai, M. Hashimoto, K. Fukase, S. Kusumoto, H. Ishida, M. Kiso, and T. Ogawa. 2003. Cell activation by monosaccharide lipid A analogoues utilizing Toll-like receptor-4. Immunology 110: 66-72.
29. Majde, J. 2000. Viral double-stranded RNA, cytokines, and the flu. J. Interferon Cytokine Res. 20: 259.
30. Dziarski, R. 1982. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. In vitro studies. J. Immunol. 128: 1018-1025.
31. Dziarski, R. 1982. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. II. In vivo studies. J. Immunol. 128: 1026-1030.
32. Su, S., M. M. Ward, M. A. Apicella, and R. E. Ward. 1991. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-I lineage. J. Immunol. 146: 327-331.
33. Murakami, M., T. Tsubata, R. Shinkura, S. Nistani, M. Okamoto, H. Yoshioka, T. Usui, S. Miyawaki, and T. Honjo. 1994. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180: 111-121.
34. Murakami, M., K. Nakajima, K.-I. Yamazaki, T. Muraguchi, T. Serikawa, and T. Honjo. 1997. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J. Exp. Med. 185: 791-794.
35. Mokuno, Y., T. Matsuguchi, M. Takano, H. Nishimura, J. Washizu, T. Ogawa, O. Takeuchi, S. Akira, Y. Nimura, and Y. Yoshikai. 2000. Expression of Toll-like receptor 2 on γδ T cells bearing invariant Vγ6/Vδ 1 induced by Escherichia coli infection in mice. J. Immunol. 165: 931-940.
36. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
37. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
38. Shimizu, H., T. Matsuguchi, Y. Fukuda, I. Nakano, T. Hayakawa, O. Takeuchi, S. Akira, M. Umemura, T. Suda, and Y. Yoshikai. 2002. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 123: 1265-1277.
39. Hiromatsu, T., T. Matsuguchi, H. Shimizu, T. Yajima, H. Nishimura, T. Arai, Y. Nimura, and Y. Yoshikai. 2003. NK T cells stimulated with a ligand for TLR2 at least partly contribute to liver injury caused by Escherichia coli infection in mice. Ear. J. Immunol. 33: 2511-2519.
40. Dunzendorer, S., H.-K. Lee, K. Soldau, and P. S. Tobias. 2004. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J. Immunol. 173: 1160-1070.
41. Zhou, D., J. Mattner, C. Cantu, 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glyciosphingolipid recognition by NKT cells. Science 306: 1687-169.
42. Goff, R. D., C. Cantu, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, H. Kasper, O. Scheneewind, D. Walker, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
43. Kamradt, T., and N. A. Mitchison. 2001. Tolerance and autoimmunity. N. Engl. J. Med. 344: 655-664.
44. Waldner, H., M. Collins, and V. K. Kuchroo. 2004. Activation of antigen-presenting cells by microbioal products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 113: 990-997.
45. Seki, N., Y. Sudo, T. Yoshioka, S. Sugihara, T. Fujitsu, S. Sakuma, T. Ogawa, T. Hamaoka, H. Senoh, and H. Fujiwara. 1988. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 140: 1477-1484.
46. Edwards, J. C., L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D. R. Close, R. M. Stevens, and T. Shaw. 2004. Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350: 2572-2581.
47. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100: 144-148.
48. Itakura, A., M. Szczepanik, R. A. Campos, V. Paliwal, M. Majewska, H. Matsuda, K. Takatsu, and P. W. Askenase. 2005. An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within one day they produce IgM antibodies that initiate elicitation of contact sensitivity. J. Immunol. In press.